Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000699205 | SCV000827905 | pathogenic | Cenani-Lenz syndactyly syndrome; Sclerosteosis 2; Congenital myasthenic syndrome 17 | 2017-11-09 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with LRP4-related disease. This sequence change creates a premature translational stop signal (p.Glu956*) in the LRP4 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). Loss-of-function variants in LRP4 are known to be pathogenic (PMID: 23636941, 24924585). For these reasons, this variant has been classified as Pathogenic. |